Pfizer Inc (PFE)
Total asset turnover
| Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue (ttm) | US$ in thousands | 58,497,000 | 68,538,000 | 77,944,000 | 92,952,000 | 100,331,000 | 100,771,000 | 101,921,000 | 92,738,000 | 81,285,000 | 63,407,000 | 51,332,000 | 44,201,000 | 41,650,000 | 47,096,000 | 47,667,000 | 49,131,000 | 50,098,000 | 51,534,000 | 52,176,000 | 52,443,000 |
| Total assets | US$ in thousands | 227,000,000 | 215,021,000 | 220,000,000 | 195,617,000 | 197,000,000 | 195,350,000 | 195,290,000 | 183,841,000 | 181,000,000 | 179,188,000 | 169,920,000 | 158,818,000 | 154,229,000 | 178,983,000 | 178,000,000 | 166,000,000 | 167,594,000 | 170,000,000 | 156,000,000 | 155,421,000 |
| Total asset turnover | 0.26 | 0.32 | 0.35 | 0.48 | 0.51 | 0.52 | 0.52 | 0.50 | 0.45 | 0.35 | 0.30 | 0.28 | 0.27 | 0.26 | 0.27 | 0.30 | 0.30 | 0.30 | 0.33 | 0.34 |
December 31, 2023 calculation
Total asset turnover = Revenue (ttm) ÷ Total assets
= $58,497,000K ÷ $227,000,000K
= 0.26
Pfizer Inc.'s total asset turnover ratio has shown fluctuation over the past eight quarters. The ratio measures the company's ability to generate sales in relation to its total assets.
In Q4 2023, the total asset turnover ratio was 0.26, indicating that Pfizer generated $0.26 in sales for every $1 of assets. This ratio increased to 0.32 in Q3 2023, suggesting improved efficiency in asset utilization. However, the ratio declined in Q2 2023 to 0.35 and further dropped in Q1 2023 to 0.48.
Comparing the most recent data with the same quarter in the previous year, there is a noticeable decrease in total asset turnover from Q4 2022 (0.51) to Q4 2023 (0.26). This could signal challenges in efficiently utilizing assets to generate sales.
Although the ratio was relatively stable in the range of 0.50 to 0.52 throughout Q1 to Q3 2022, it decreased slightly in Q4 2022 to 0.51. This pattern suggests that Pfizer's efficiency in generating sales from its assets has been uneven.
In summary, Pfizer Inc.'s total asset turnover ratio has experienced fluctuations, indicating varying levels of efficiency in utilizing assets to generate sales over the past eight quarters. Additional analysis would be required to understand the reasons behind these fluctuations and their potential impact on the company's financial performance.
Peer comparison
Dec 31, 2023